Q3 2016 13F Holders as of 30 Sep 2016
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
58,643,980
-
Number of holders
-
160
-
Total 13F shares, excl. options
-
37,828,945
-
Shares change
-
+4,797,501
-
Total reported value, excl. options
-
$1,997,518,488
-
Value change
-
+$255,912,326
-
Put/Call ratio
-
77.33%
-
Number of buys
-
102
-
Number of sells
-
-56
-
Price
-
$52.82
Significant Holders of AGIOS PHARMACEUTICALS, INC. - Common Stock (AGIO) as of Q3 2016
198 filings reported holding AGIO - AGIOS PHARMACEUTICALS, INC. - Common Stock as of Q3 2016.
AGIOS PHARMACEUTICALS, INC. - Common Stock (AGIO) has 160 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 37,828,945 shares
of 58,643,980 outstanding shares and own 64.51% of the company stock.
Largest 10 shareholders include FMR LLC (6,211,072 shares), WELLINGTON MANAGEMENT GROUP LLP (5,798,331 shares), BB BIOTECH AG (2,649,528 shares), VANGUARD GROUP INC (2,364,221 shares), Capital International Investors (1,504,896 shares), Clearbridge Investments, LLC (1,458,751 shares), PRICE T ROWE ASSOCIATES INC /MD/ (1,239,924 shares), STATE STREET CORP (1,090,341 shares), Flagship Ventures Management, Inc. (965,369 shares), and BALYASNY ASSET MANAGEMENT LLC (920,704 shares).
This table shows the top 160 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.